Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Monash IVF Group.
RELATED STOCKHEAD STORIES
Health & Biotech
Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August
Health & Biotech
ScoPo’s Powerplays: ‘Ansell is a buy’, while all eyes are on ImpediMed’s upcoming publication
Health & Biotech
ScoPo’s Powerplays: Quality names continue to catch a bid as earnings roll in
Experts
ScoPo’s Powerplays: Budget boost and inflation fears meet head on
Experts
ScoPo’s health powerplays: What to look for this earnings season
Experts
ScoPo’s powerplays: Searching for gems as healthcare sector languishes
Experts
ScoPo’s powerplays: ‘It’s going to be a great run into 2021’
Experts
Scopo’s health powerplays: A healthy earnings season
Health & Biotech
Virtus pitches AI tech to get out of IVF price war
Experts
Scopo’s powerplays: Investors love a result, until they don’t
Experts
Scopo’s powerplays: Hemp hippies and wellness wonderlands
News
Short & Caught: The ASX small caps investors are shorting right now
Experts
Scopo’s health powerplays: Markets are getting back to normal
Health & Biotech
The elective surgery stocks getting a boost from the easing of COVID-19 restrictions
Director Trades
Directors Trades: There’s been an avalanche of big trades in recent days
Experts